茶黄素双没食子酸酯对高脂饮食诱导小鼠肝脏损伤的影响及机制探讨

张淦; 付红娟; 邹奕昕; 邓志慧; 常徽

doi:10.16016/j.2097-0927.202107051

您当前的位置：

首页 >

文章列表页 >

茶黄素双没食子酸酯对高脂饮食诱导小鼠肝脏损伤的影响及机制探讨

基础医学 | 更新时间：2026-01-09

- 茶黄素双没食子酸酯对高脂饮食诱导小鼠肝脏损伤的影响及机制探讨
- Effects of theaflavin-3, 3'-digallate on high-fat diet-induced liver injury in mice and its mechanism
- 陆军军医大学学报 2022年44卷第2期页码：147-154
- 作者机构：
  
  400715 重庆，西南大学食品科学学院，食品科学与工程国家级实验教学示范中心
- 作者简介：
  
  [常徽，E-mail: changhui2017@swu.edu.ed CHANG Hui, E-mail: changhui2017@swu.edu.ed
- 基金信息：
  
  西南大学大学生创新创业训练项目(X202110635215)
- DOI：10.16016/j.2097-0927.202107051
  中图分类号： R151.41;R575.5;R589.2
- 收稿：2021-07-08，
  
  修回：2021-09-27，
  
  纸质出版：2022-01-30
- 稿件说明：
移动端阅览
张淦, 付红娟, 邹奕昕, 等. 茶黄素双没食子酸酯对高脂饮食诱导小鼠肝脏损伤的影响及机制探讨[J]. 陆军军医大学学报, 2022,44(2):147-154.

Gan ZHANG, Hongjuan FU, Yixin ZOU, et al. Effects of theaflavin-3, 3'-digallate on high-fat diet-induced liver injury in mice and its mechanism[J]. Journal of Army Medical University, 2022, 44(2): 147-154.
张淦, 付红娟, 邹奕昕, 等. 茶黄素双没食子酸酯对高脂饮食诱导小鼠肝脏损伤的影响及机制探讨[J]. 陆军军医大学学报, 2022,44(2):147-154. DOI： 10.16016/j.2097-0927.202107051.

Gan ZHANG, Hongjuan FU, Yixin ZOU, et al. Effects of theaflavin-3, 3'-digallate on high-fat diet-induced liver injury in mice and its mechanism[J]. Journal of Army Medical University, 2022, 44(2): 147-154. DOI： 10.16016/j.2097-0927.202107051.

摘要

目的

探讨茶黄素-3

3’-双没食子酸酯(theaflavin-3

3’-digallate，TFDG)膳食干预对高脂饮食诱导小鼠肝脏损伤的保护效应及相关机制。

方法

将C57BL/6小鼠按随机数字表法分为对照组(NC)、模型组(MC)、TFDG干预组(TF5和TF10)，NC组喂食普通饲料，其余3组喂食高脂饲料，TF5和TF10组分别以5 mg/kg和10 mg/kg TFDG灌胃，NC和MC组以生理盐水灌胃，分组处理12周；检测小鼠肝指数、血清谷丙转氨酶(ALT)和谷草转氨酶(AST)水平，观察肝组织病理形态学变化，ELISA检测肝组织炎症因子水平，Western blot检测蛋白表达水平，qRT-PCR检测miR-223水平。

结果

高脂饮食诱导小鼠肝指数显著升高，血清ALT和AST水平明显上升，TFDG膳食干预可有效降低以上肝功指标(

0.05)；病理学观察表明，TFDG干预减少肝组织脂滴形成，脂含量检测结果也表明，TFDG干预显著降低肝组织TG和TC的含量(

0.05)；ELISA结果显示，高脂饮食诱导小鼠肝脏IL-1β、IL-6和TNF-α水平显著升高，TFDG干预可显著抑制肝脏炎症反应(

0.05)；Western blot检测结果显示，高脂饮食小鼠肝脏NLRP3、caspase-1和IL-1β的表达明显升高，TFDG干预可显著抑制NLRP3炎症通路激活(

0.05)。TFDG干预可显著上调高脂条件下肝细胞miR-223的表达，以miR-223寡核苷酸抑制物阻断TFDG对miR-223表达的影响后，其对炎症反应的抑制作用显著降低(

0.05)。

结论

TFDG可有效减轻高脂饮食诱导的肝脏损伤及炎症反应，其机制可能是通过上调miR-223抑制NLRP3通路实现的。

Abstract

Objective

To investigate the protective effects of dietary intervention with theaflavin-3

3'-digallate (TFDG) on liver injury induced by high-fat diet (HFD) in mice and its underlying mechanism.

Methods

Forty C57BL/6 mice were randomly and equally divided into normal control (NC)

model control (MC) and TFDG administration (TF5 and TF10) groups. The mice of the NC group were fed with normal diet

and those of the other 3 groups were given HFD. Then the TF5 and TF10 groups were intragastrically given 5 mg/kg and 10 mg/kg TFDG respectively

while the NC and MC groups were treated with normal saline. After 12 weeks of intervention

the liver index

serum ALT and AST levels were detected

and the pathological changes of liver tissues were observed in the mice. The contents of inflammatory factors and the expression levels of related proteins in liver tissue were determined by ELISA and Western blotting respectively

and the mRNA level of miR-233 was measured by qRT-PCR.

Results

HFD significantly increased the liver index as well as serum ALT and AST levels

while these changes were effectively reversed by TFDG administration (

0.05). Pathological observation displayed that TFDG intervention reduced the formation of lipid droplets in liver tissue

and lipid content detection also suggested that TFDG remarkably declined the levels of triglyceride (TG) and total cholesterol (TC) in liver tissue (

0.05). ELISA indicated that the levels of IL-1β

IL-6 and TNF-α were elevated notably in the liver of HFD-fed mice

and Western blotting confirmed higher protein levels of NLRP3

caspase-1 and IL-1β

whereas TFDG inhibited the inflammatory response of liver (

0.05) and the activation of NLRP3/IL-1β pathway (

0.05). In addition

TFDG intervention greatly up-regulated the expression of miR-223 in the hepatocytes under high-fat condition. After oligonucleotide in

hibitor blocked the effect of TFDG on miR-223 expression

its inhibitory effect on inflammatory response was weakened as well (

0.05).

Conclusion

TFDG can effectively alleviate liver injury and inflammatory response induced by HFD

which may be through up-regulation of miR-223 to inhibiting NLRP3 pathway.

关键词

Keywords

references

LI J, ZOU B, YEO Y H, et al . Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis[J ] . Lancet Gastroenterol Hepatol, 2019, 4(5): 389-398. DOI: 10.1016/s2468-1253(19)30039-1.

LEBEAUPIN C, VALLÉE D, HAZARI Y, et al . Endoplasmic Reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease[J ] . J Hepatol, 2018, 69(4): 927-947. DOI: 10.1016/j.jhep.2018.06.008.

TAKEMOTO M, TAKEMOTO H. Synthesis of theaflavins and their functions[J]. Molecules, 2018, 23(4): 918. DOI: 10.3390/molecules23040918.

PEREIRA-CARO G, MORENO-ROJAS J M, BRINDANI N, et al . Bioavailability of black tea theaflavins: absorption, metabolism, and colonic catabolism[J ] . J Agric Food Chem, 2017, 65(26): 5365-5374. DOI: 10.1021/acs.jafc.7b01707.

HE H F. Research progress on theaflavins: efficacy, formation, and preparation[J]. Food Nutr Res, 2017, 61(1): 1344521. DOI: 10.1080/16546628.2017.1344521.

冯巩, 贺娜, 王菊宁, 等. 非酒精性脂肪性肝病的流行病学与血清无创诊断研究进展[J]. 中华肝脏病杂志, 2018, 26(6): 476-480. DOI: 10.3760/cma.j.issn.1007-3418.2018.06.020.

FENG G, HE N, WANG J N, et al . Advances in epidemiology and serum markers for the noninvasive diagnosis of nonalcoholic fatty liver disease[J ] . Chin J Hepatol, 2018, 26(6): 476-480. DOI: 10.3760/cma.j.issn.1007-3418.2018.06.020.

朱国英, 黄东平, 黄建伟, 等. ω-3多不饱和脂肪酸联合膳食营养对非酒精性脂肪性肝病患者的影响[J]. 同济大学学报(医学版), 2017, 38(2): 79-83. DOI: 10.16118/j.1008-0392.2017.02.016.

ZHU G Y, HUANG D P, HUANG J W, et al . Effectiveness of combined Omega-3 polyunsaturated fatty acids with dietary nutrition in patients with non-alcoholic fatty liver disease[J ] . J Tongji Univ Med Sci, 2017, 38(2): 79-83. DOI: 10.16118/j.1008-0392.2017.02.016.

MAHADY S E, WONG G, CRAIG J C, et al . Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis[J ] . Hepatology, 2012, 56(6): 2172-2179. DOI: 10.1002/hep.25887.

陈洁, 陈佳良, 肖琨珉, 等. 炎症因子与非酒精性脂肪性肝病关系研究进展[J]. 医学综述, 2019, 25(15): 2949-2954. DOI: 10.3969/j.issn.1006-2084.2019.15.007.

CHEN J, CHEN J L, XIAO K M, et al . Research advances in relationship between nonalcoholic fatty liver disease and inflammatory factors[J ] . Med Recapitul, 2019, 25(15): 2949-2954. DOI: 10.3969/j.issn.1006-2084.2019.15.007.

MEHAL W Z. The inflammasome in liver injury and non-alcoholic fatty liver disease[J]. Dig Dis, 2014, 32(5): 507-515. DOI: 10.1159/000360495.

王晓晓, 饶慧瑛, 刘峰. 非酒精性脂肪性肝病发病机制研究进展: 聚焦"巨噬细胞及其分子机制"[J]. 医学综述, 2019, 25(15): 2929-2934. DOI: 10.3969/j.issn.1006-2084.2019.15.004.

WANG X X, RAO H Y, LIU F. Research progress in pathogenesis of nonalcoholic fatty liver disease-focusing on "macrophages and related molecular mechanisms"[J]. Med Recapitul, 2019, 25(15): 2929-2934. DOI: 10.3969/j.issn.1006-2084.2019.15.004.

KAKINO S, OHKI T, NAKAYAMA H, et al . Pivotal role of TNF-α in the development and progression of nonalcoholic fatty liver disease in a murine model[J ] . Horm Metab Res, 2018, 50(1): 80-87. DOI: 10.1055/s-0043-118666.

王子媛, 郑涛, 陈黎, 等. NLRP3炎症小体在非酒精性脂肪性肝病中作用的研究进展[J]. 山东医药, 2021, 61(10): 84-87. DOI: 10.3969/j.issn.1002-266X.2021.10.021.

WANG Z Y, ZHENG T, CHEN L, et al . Advances in the study of the role of NLRP3 inflammatory cartilage in non-alcoholic fatty liver disease[J ] . Shandong Med J, 2021, 61(10): 84-87. DOI: 10.3969/j.issn.1002-266X.2021.10.021.

HAMARSHEH S, ZEISER R. NLRP3 inflammasome activation in cancer: a double-edged sword[J]. Front Immunol, 2020, 11: 1444. DOI: 10.3389/fimmu.2020.01444.

WAN X, XU C, YU C, et al . Role of NLRP3 inflammasome in the progression of NAFLD to NASH[J ] . Can J Gastroenterol Hepatol, 2016, 2016: 6489012. DOI: 10.1155/2016/6489012.

邓涛, 龚建平, 何堃. NLRP3基因敲除对非酒精性脂肪性肝炎小鼠的影响[J]. 山东医药, 2019, 59(1): 1-4. DOI: 10.3969/j.issn.1002-266X.2019.01.001.

DENG T, GONG J P, HE K. Effect of knockout of NLRP3 gene on non-alcoholic steatohepatitis mice[J]. Shandong Med J, 2019, 59(1): 1-4. DOI: 10.3969/j.issn.1002-266X.2019.01.001.

JEFFRIES J, ZHOU W, HSU A Y, et al . miRNA-223 at the crossroads of inflammation and cancer[J ] . Cancer Lett, 2019, 451: 136-141. DOI: 10.1016/j.canlet.2019.02.051.

NEUDECKER V, HANEKLAUS M, JENSEN O, et al . Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome[J ] . J Exp Med, 2017, 214(6): 1737-1752. DOI: 10.1084/jem.20160462..

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

富马酸二甲酯通过激活NRF2/SLC7A11轴抑制肺上皮细胞铁死亡并调控巨噬细胞极化缓解高原低氧急性肺损伤

复方营养制剂干预对心血管外科手术患者临床预后影响的随机对照研究

2.65 GHz射频长期辐射对小鼠机体炎症反应和肠道微生态的影响

铁抑素-1通过抑制肺上皮细胞铁死亡减轻高原低氧肺损伤炎症反应

一种复方营养制剂对大鼠急性创伤后伤口愈合的影响研究